What is the current Price Target for the Dyne Therapeutics Inc stock?

The average Dyne Therapeutics Inc target price is $36.72. This is 73.45% higher than the current stock price. The highest price target is 147.99%, the lowest is -57.06%. 18 Analysts have issued a price target Dyne Therapeutics Inc 2026 .

How high will the Dyne Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Dyne Therapeutics Inc stock will rise. The performance of stocks, including the Dyne Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Dyne Therapeutics Inc stock today?

The performance of Dyne Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Dyne Therapeutics Inc stock fall?

The decline in Dyne Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Dyne Therapeutics Inc Forecast, price target & analysts

$21.33

0.76% yesterday

Nasdaq, Nov 28, 03:50 pm CET

ISIN

US26817R1086

Symbol

DYN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Dyne Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Dyne Therapeutics Inc Classifications & Recommendation:

Buy

81%

Hold

19%

Dyne Therapeutics Inc Price Target

Target Price	$36.72
Price	$21.17
Potential	73.45% register free of charge
Number of Estimates	18

	18 Analysts have issued a price target Dyne Therapeutics Inc 2026 . The average Dyne Therapeutics Inc target price is $36.72. This is 73.45% register free of charge higher than the current stock price. The highest price target is $52.50 147.99% register free of charge , the lowest is $9.09 57.06% register free of charge .
	A rating was issued by 21 analysts: 17 Analysts recommend Dyne Therapeutics Inc to buy, 4 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Dyne Therapeutics Inc stock has an average upside potential 2026 of 73.45% register free of charge . Most analysts recommend the Dyne Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.37	-3.70
	14.68%	9.79%
P/E		negative

18 Analysts have issued a Dyne Therapeutics Inc forecast for earnings per share. The average Dyne Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.37	14.68%
2025	$-3.70 9.79% Unlock
2026	$-3.56 3.78% Unlock
2027	$-3.10 12.92% Unlock
2028	$-2.01 35.16% Unlock
2029	$0.55 127.36% Unlock
2030	$3.07 458.18% Unlock
2031	$5.12 66.78% Unlock
2032	$7.04 37.50% Unlock

Current	-7.10	30.37%
2025	-5.72 19.48% Unlock
2026	-5.94 3.85% Unlock
2027	-6.84 15.15% Unlock
2028	-10.54 54.09% Unlock
2029	38.64 466.60% Unlock
2030	6.90 82.14% Unlock
2031	4.13 40.14% Unlock
2032	3.01 27.12% Unlock

Dyne Therapeutics Inc...

Current Dyne Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Nov 14 2025
Oppenheimer	Locked ➜ Locked	Locked	Nov 12 2025
RBC Capital	Locked ➜ Locked	Locked	Nov 06 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 06 2025
Oppenheimer	Locked ➜ Locked	Locked	Oct 10 2025
Raymond James	Locked ➜ Locked	Locked	Aug 25 2025
Oppenheimer	Locked ➜ Locked	Locked	Aug 06 2025

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Nov 14 2025
Locked Oppenheimer: Locked ➜ Locked	Nov 12 2025
Locked RBC Capital: Locked ➜ Locked	Nov 06 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 06 2025
Locked Oppenheimer: Locked ➜ Locked	Oct 10 2025
Locked Raymond James: Locked ➜ Locked	Aug 25 2025
Locked Oppenheimer: Locked ➜ Locked	Aug 06 2025

Discover more stocks with a high price target

Netflix 1,235.78%

Coinbase Global, Inc. 55.52%

Adidas 50.19%

Novo Nordisk 50.10%

Rheinmetall 48.22%

Meta Platforms (Facebook) 40.86%

Deutsche Telekom 40.79%

BioNTech SE - ADR 35.57%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now